140 results
Page 3 of 7
8-K
EX-99.1
f5h95m
23 Oct 19
Regulation FD Disclosure
5:11pm
8-K
EX-99.1
tko fosicvmwy96az9
7 Aug 19
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
41lhy1 4jl
2 May 19
Teva Reports First Quarter 2019 Financial Results
7:00am
8-K
EX-99.1
m5x b879n
13 Feb 19
Teva Reports Fourth Quarter and Full Year 2018 Financial Results
7:00am
8-K
EX-99.1
hairuzf1hceb
1 Nov 18
Teva Reports Third Quarter 2018 Financial Results
7:02am
8-K
EX-99.1
9qyrcje91bsk
2 Aug 18
Teva Reports Second Quarter 2018 Financial Results
7:00am
10-Q
tlrhjm5cm
3 May 18
Quarterly report
4:08pm
8-K
EX-99.1
ox4cb icwk
3 May 18
Teva Reports First Quarter 2018 Financial Results
12:00am
424B3
klfp r3ufd
19 Apr 18
Prospectus supplement
12:00am
10-K
ljyu4
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
6ts96b tiyi
27 Dec 17
Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States
12:00am
6-K
EX-99.1
xbwg89q8r oczydl
27 Nov 17
Teva Announces New Organization Structure and Leadership Changes
12:00am
6-K
EX-99.1
fjin6gz0 tfl2wq6h
18 Aug 17
Teva Announces Exclusive Launch of Generic Axiron® In the United States
12:00am
6-K
EX-99.1
izfgivvasyi65lm
24 Jul 17
Live Filing
12:00am
6-K
EX-99.1
18xsqz8xto
7 Jun 17
Live Filing
12:00am